127 related articles for article (PubMed ID: 1660312)
21. Longitudinal study of anticentromere and antitopoisomerase-I isotypes.
Vázquez-Abad D; Russell CA; Cusick SM; Earnshaw WC; Rothfield NF
Clin Immunol Immunopathol; 1995 Mar; 74(3):257-70. PubMed ID: 7859416
[TBL] [Abstract][Full Text] [Related]
22. Use of molecular cloning methods to map the distribution of epitopes on topoisomerase I (Scl-70) recognized by sera of scleroderma patients.
D'Arpa P; White-Cooper H; Cleveland DW; Rothfield NF; Earnshaw WC
Arthritis Rheum; 1990 Oct; 33(10):1501-11. PubMed ID: 1699543
[TBL] [Abstract][Full Text] [Related]
23. Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies.
Krzyszczak ME; Li Y; Ross SJ; Ceribelli A; Chan EK; Bubb MR; Sobel ES; Reeves WH; Satoh M
Clin Rheumatol; 2011 Oct; 30(10):1333-9. PubMed ID: 21523365
[TBL] [Abstract][Full Text] [Related]
24. Marker antibodies in scleroderma and polymyositis: clinical associations.
de Rooij DJ; Van de Putte LB; Habets WJ; Van Venrooij WJ
Clin Rheumatol; 1989 Jun; 8(2):231-7. PubMed ID: 2547546
[TBL] [Abstract][Full Text] [Related]
25. Detection of anti-topoisomerase I antibodies using a full length human topoisomerase I recombinant protein purified from a baculovirus expression system.
Whyte J; Earnshaw WC; Champoux JJ; Parker LH; Stewart L; Hall ND; McHugh NJ
Clin Exp Immunol; 1995 May; 100(2):214-8. PubMed ID: 7743657
[TBL] [Abstract][Full Text] [Related]
26. Anti-topoisomerase I autoantibodies in systemic sclerosis.
Czömpöly T; Simon D; Czirják L; Németh P
Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of anti-DNA topoisomerase I autoantibody response after lung cancer in patients with systemic sclerosis. A report of two cases.
Kuwana M; Fujii T; Mimori T; Kaburaki J
Arthritis Rheum; 1996 Apr; 39(4):686-91. PubMed ID: 8630122
[TBL] [Abstract][Full Text] [Related]
28. MHC class II associations with autoantibody and T cell immune responses to the scleroderma autoantigen topoisomerase I.
Rands AL; Whyte J; Cox B; Hall ND; McHugh NJ
J Autoimmun; 2000 Dec; 15(4):451-8. PubMed ID: 11090244
[TBL] [Abstract][Full Text] [Related]
29. [Anti-Scl-70 and anti-centromere autoantibodies. Biological markers of 2 forms of systemic scleroderma].
Johanet C; Agostini MM; Vayssairat M; Abuaf N
Presse Med; 1989 Feb; 18(5):207-11. PubMed ID: 2522207
[TBL] [Abstract][Full Text] [Related]
30. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients.
Hénault J; Robitaille G; Senécal JL; Raymond Y
Arthritis Rheum; 2006 Mar; 54(3):963-73. PubMed ID: 16508979
[TBL] [Abstract][Full Text] [Related]
31. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
[TBL] [Abstract][Full Text] [Related]
32. Identification of a universal B cell epitope on DNA topoisomerase I, an autoantigen associated with scleroderma.
Kato T; Yamamoto K; Takeuchi H; Okubo M; Hara E; Nakada S; Oda K; Ito K; Nishioka K
Arthritis Rheum; 1993 Nov; 36(11):1580-7. PubMed ID: 7694585
[TBL] [Abstract][Full Text] [Related]
33. Autoantibodies against topoisomerase I detected with the natural enzyme and overlapping recombinant peptides.
Seelig HP; Schröter H; Ehrfeld H; Renz M
J Immunol Methods; 1993 Oct; 165(2):241-52. PubMed ID: 8228274
[TBL] [Abstract][Full Text] [Related]
34. Analysis of anti-topoisomerase I antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation.
Henes J; Glaeser L; Kötter I; Vogel W; Kanz L; Klein R
Rheumatology (Oxford); 2017 Mar; 56(3):451-456. PubMed ID: 27940597
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study.
Weiner ES; Hildebrandt S; Senécal JL; Daniels L; Noell S; Joyal F; Roussin A; Earnshaw W; Rothfield NF
Arthritis Rheum; 1991 Jan; 34(1):68-77. PubMed ID: 1845841
[TBL] [Abstract][Full Text] [Related]
36. Molecular recognition patterns of anti-topoisomerase I-antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation.
Glaeser L; Henes J; Kötter I; Vogel W; Kanz L; Klein R
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):28-35. PubMed ID: 29465357
[TBL] [Abstract][Full Text] [Related]
37. Association of autoantibodies to topoisomerase I and the phosphorylated (IIO) form of RNA polymerase II in Japanese scleroderma patients.
Satoh M; Kuwana M; Ogasawara T; Ajmani AK; Langdon JJ; Kimpel D; Wang J; Reeves WH
J Immunol; 1994 Dec; 153(12):5838-48. PubMed ID: 7989779
[TBL] [Abstract][Full Text] [Related]
38. Idiotypic analysis of human anticentromere autoantibodies.
Hildebrandt S; Weiner ES; Earnshaw WC; Zanetti M; Rothfield NF
Autoimmunity; 1991; 9(2):131-40. PubMed ID: 1657226
[TBL] [Abstract][Full Text] [Related]
39. Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis?
Diot E; Giraudeau B; Diot P; Degenne D; Ritz L; Guilmot JL; Lemarié E
Chest; 1999 Sep; 116(3):715-20. PubMed ID: 10492277
[TBL] [Abstract][Full Text] [Related]
40. Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I.
Guldner HH; Szostecki C; Vosberg HP; Lakomek HJ; Penner E; Bautz FA
Chromosoma; 1986; 94(2):132-8. PubMed ID: 2428564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
